4.90
Finanzdaten der Foghorn Therapeutics Inc-Aktie (FHTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
7.89%
8.153
|
7.557 | 5.952 | 2.856 | 7.808 |
|
|
6.98%
26.65
|
28.65 | 28.86 | 26.86 | 31.66 |
| Benefits Costs and Expenses |
-
|
- | - | 22.36 | 26.93 |
| Costs And Expenses |
6.98%
26.65
|
28.65 | 28.86 | 22.36 | 26.93 |
| Operating Income/Loss |
12.31%
-18.50
|
-21.10 | -22.91 | -24.00 | -23.85 |
| Nonoperating Income/Loss |
16.10%
2.652
|
3.161 | 4.079 | 4.502 | 4.73 |
| Income/Loss From Continuing Operations Before Tax |
145.46%
8.153
|
-17.94 | -18.83 | -19.50 | -19.12 |
| Income/Loss From Continuing Operations After Tax |
11.64%
-15.85
|
-17.94 | -18.83 | -19.50 | -19.12 |
|
|
11.64%
-15.85
|
-17.94 | -18.83 | -19.50 | -19.12 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.08%
63.03
|
62.98 | 62.85 | 2.6575 | 62.60 |
| Diluted Average Shares |
0.08%
63.03
|
62.98 | 62.85 | 2.6575 | 62.60 |
| Basic Earnings Per Share |
10.71%
-0.25
|
-0.28 | -0.30 | -0.30 | -0.31 |
| Diluted Earnings Per Share |
10.71%
-0.25
|
-0.28 | -0.30 | -0.30 | -0.31 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):